NCT01668719 · MORE INFO

Limitations, agreements, and source contact

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma · Source last updated 2026-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: rachaels@crab.org
organization: SWOG Statistics and Data Management Center
phone: 2066674623
title: Myeloma Committee Statistician

Complete source fields

certain Agreement

pi Sponsor Employee: false
restriction Type: LTE60
restrictive Agreement: true

point Of Contact

email: rachaels@crab.org
organization: SWOG Statistics and Data Management Center
phone: 2066674623
title: Myeloma Committee Statistician

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice